
trading places
Practical Venture Capital
a very bad 💩podcast about VC secondaries broken unicorns ❤️🩹🦄 & busted carry 📉🙈
Anthropic $1.3T IPO, US Data Center Backlash, Brazil Election Shock & Eric Woo on Emerging Managers
Episode discussion: Anthropic IPO Pricing, Data Center Political Risks, and Emerging Manager Liquidity Strategies
Speakers’ claims: Speakers analyze Anthropic's IPO reset to a $1.3T valuation, noting institutional pushback and a downsized share count. They discuss political headwinds for US data centers, including Democratic governor control in key states and local ballot measures, while contrasting this with OpenAI's stalled Argentine investments. The episode also covers the Tesla-SpaceX merger outlook, crypto trends in Latin America, and insights from Eric Woo and Dave McClure on emerging manager liquidity, continuation vehicles, and the impact of AI on early-stage venture financing.
Blue Wave Hits AI: Google $500B Wipeout, Neocloud Credit Crunch & Kalshi at $40B
Episode discussion: AI Capex Surge, Google Wipeout, and Prediction Market Valuations
Speakers’ claims: Speakers analyze the massive capital intensity of AI infrastructure, noting Meta's $95B stock raise and Google's $500B market value loss due to cash flow concerns. They highlight a credit crunch driven by hyperscaler spending, which has increased AI-affiliated debt issuance sixfold year-over-year, distressing neoclouds like CoreWeave. The episode contrasts traditional sports betting incumbents with prediction markets, citing Kalshi's $40B valuation and Polymarket's $21B valuation as evidence of a shifting landscape. Speakers argue that prediction markets offer superior fee structures and revenue diversification compared to saturated sportsbooks.
5 Things 'You Can See Everything' Gets Wrong About Elizabeth Holmes
Episode discussion: Review of 'Now You See Everything' documentary on Elizabeth Holmes and Theranos omissions
Speakers’ claims: Speaker 0 reviews the documentary 'Now You See Everything,' noting it blends film critique with startup founder topics. He highlights omissions in the film regarding Theranos' revenue, use of Pfizer's logo, and Holmes' loans. The speaker contrasts the film's narrative with his own experience interviewing for the CFO role in 2015. He praises the filmmaking quality but criticizes the documentary's lack of diligence, rating it 9.3 on IMDb. The episode concludes with advice to avoid future Theranos-related investment pitches.